Ramos-Nieves, R.; Armina-Rodriguez, A.; Figueroa-Gispert, M.D.M.; Figueroa-Quiñones, G.; Ocasio-Malavé, C.; Espino, A.M.
A Modified Variant of Fasciola hepatica FhSAP-2 (mFhSAP-2) as a Recombinant Vaccine Candidate Induces High-Avidity IgG2c Antibodies and Enhances T Cell Activation in C57BL/6 Mice. Vaccines 2025, 13, 545.
https://doi.org/10.3390/vaccines13050545
AMA Style
Ramos-Nieves R, Armina-Rodriguez A, Figueroa-Gispert MDM, Figueroa-Quiñones G, Ocasio-Malavé C, Espino AM.
A Modified Variant of Fasciola hepatica FhSAP-2 (mFhSAP-2) as a Recombinant Vaccine Candidate Induces High-Avidity IgG2c Antibodies and Enhances T Cell Activation in C57BL/6 Mice. Vaccines. 2025; 13(5):545.
https://doi.org/10.3390/vaccines13050545
Chicago/Turabian Style
Ramos-Nieves, Riseilly, Albersy Armina-Rodriguez, Maria Del Mar Figueroa-Gispert, Ghalib Figueroa-Quiñones, Carlimar Ocasio-Malavé, and Ana M. Espino.
2025. "A Modified Variant of Fasciola hepatica FhSAP-2 (mFhSAP-2) as a Recombinant Vaccine Candidate Induces High-Avidity IgG2c Antibodies and Enhances T Cell Activation in C57BL/6 Mice" Vaccines 13, no. 5: 545.
https://doi.org/10.3390/vaccines13050545
APA Style
Ramos-Nieves, R., Armina-Rodriguez, A., Figueroa-Gispert, M. D. M., Figueroa-Quiñones, G., Ocasio-Malavé, C., & Espino, A. M.
(2025). A Modified Variant of Fasciola hepatica FhSAP-2 (mFhSAP-2) as a Recombinant Vaccine Candidate Induces High-Avidity IgG2c Antibodies and Enhances T Cell Activation in C57BL/6 Mice. Vaccines, 13(5), 545.
https://doi.org/10.3390/vaccines13050545